Sensidose participated in BIO-Europe® 2016

Sensidose participated in BIO-Europe® 2016

Sensidose participated in BIO-Europe® 2016 – 22nd Annual International Partnering Conference Sensidose has participated in the BIO-Europe® 2016, the 22nd Annual International Partnering Conference that was held November 7-9, 2016 in Cologne, Germany. At the...
Sensidose participated in BIO-Europe® 2016

Press release

Sollentuna September 15, 2016 PRESS RELEASE The pharmaceutical company Sensidose AB announces that the company has passed important milestones: • Flexilev® for the treatment of Parkinson’s disease is subsidized in Sweden • Approved national marketing...

Sensidose participates in a Vinnova project

Sensidose participates in a Vinnova project regarding evaluation of symptoms and improved treatment of Parkinson’s disease. Vinnova has distributed 60 million SEK to projects within the area “Innovations for Future Health”. Within the framework of...

International Congress of Parkinson’s Disease

Sensidose was one of 28 exhibitors during the 18th International Congress of Parkinson’s Disease and Movement Disorders which took place between 8th to 12th of June 2014 in Stockholm. This was an excellent opportunity to present to an international audience the...